(Q44072943)

29 November 2017

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. (English)

1 reference

29 November 2017

1 reference

1 reference

1 reference

Wiedmann M

1

1 reference

29 November 2017

Liebert UG

2

1 reference

29 November 2017

Oesen U

3

1 reference

29 November 2017

Porst H

4

1 reference

29 November 2017

Wiese M

5

1 reference

29 November 2017

Schroeder S

6

1 reference

29 November 2017

Halm U

7

1 reference

29 November 2017

Mössner J

8

1 reference

29 November 2017

Berr F

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

29 November 2017

1 reference

29 November 2017

31

1 reference

29 November 2017

1

1 reference

29 November 2017

230-234

1 reference

Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults

29 November 2017

2 references

https://api.crossref.org/works/10.1002%2FHEP.510310134

21 January 2018

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Characteristics of patients with dual infection by hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Vaccination of patients with liver disease: who, when, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

Hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Hepatitis B vaccination of patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Response to hepatitis B vaccine: multiple HLA genes are involved.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Is nonresponsiveness to hepatitis B vaccine due to latent hepatitis B virus infection?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

HLA gene and haplotype frequencies in Dutch blood donors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Immunology taught by viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Persistence of specific antibodies after hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310134

7 January 2021

Identifiers

DOI

10.1002/HEP.510310134

1 reference

29 November 2017

1 reference